The North America desloratadine market is witnessing steady growth due to the region's high prevalence of seasonal and perennial allergies, established healthcare infrastructure, and broad access to antihistamine therapies. Growing emphasis on long-term allergy symptom management and demand for treatments with reduced sedative effects are supporting the adoption of desloratadine. The US remains...